March 9, 2020 / 7:08 PM / in 20 days

BRIEF-Cocrystal Pharma Announces $6.8 Million Registered Direct Offering Priced At-The-Market

March 9 (Reuters) - Cocrystal Pharma Inc:

* COCRYSTAL PHARMA ANNOUNCES $6.8 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET

* COCRYSTAL PHARMA INC - OFFERING PRICED AT $1.35 PER SHARE

* COCRYSTAL PHARMA INC - AGREEMENTS WITH SEVERAL INSTITUTIONAL INVESTORS FOR PURCHASE OF 5 MILLION SHARES OF CO’S COMMON STOCK

* COCRYSTAL PHARMA INC - INTENDS TO USE NET PROCEEDS FOR WORKING CAPITAL AND OTHER GENERAL CORPORATE PURPOSES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below